Coenzyme Q10 decreases TNF-alpha and IL-2 secretion by human peripheral blood mononuclear cells.
The beneficial effect of coenzyme Q10 (CoQ10) on human health occurs through various mechanisms including the possibility of immunomodulation. Therefore, the purpose of study was to examine the in vitro effect of CoQ10 on cytokine production and superoxide anion generation by human peripheral blood mononuclear cells (PBMC). 2x10(6)/mL PBMC obtained from 19 volunteers were incubated for 24 h without or with 0.6, 1.25, 2.5 and 5.0 muM of CoQ10. The production of the following cytokines were examined: IL-1beta, IL-1ra, IL-6, IL-10, IL-2 and IFNgamma. Superoxide anion production was examined by incubation of 4x10(6)/mL cells with CoQ10 and 2x10(-3) mM phorbol merystate acetate (PMA) for 60 min. The production of the proinflammatory cytokines IL-1beta, IL-6 and IFNgamma and that of the anti-inflammatory cytokines IL-1ra and IL-10 by PBMC was not affected by CoQ10, whereas TNFalpha secretion was significantly decreased when the cells were incubated with 0.6 and 1.25 muM of CoQ10. On the other hand, increasing doses of CoQ10 caused mild, but statistically significant inhibition of IL-2 secretion. The generation of superoxide anion by PBMC did not differ significantly between cells incubated with or without CoQ10 at concentrations between 0.3 and 5.0 muM. The results suggest that CoQ10 exerts a certain effect on cytokine production by PBMC related to its capacity to modulate human immune function.
Bessler
Hanna
H
Laboratory for Immunology and Hematology Research, affiliated with the Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Bergman
Michael
M
Blumberger
Naava
N
Djaldetti
Meir
M
Salman
Hertzel
H
D001773:Blood Cells / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D007376:Interleukin-2 / Q000378:metabolism*; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000494:pharmacology
D016207:Cytokines; D007155:Immunologic Factors; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D013481:Superoxides; D014451:Ubiquinone; C024989:coenzyme Q10